FAERS analysis maps early, diverse ifosfamide neurological adverse events
A FAERS analysis of 786 ifosfamide-related neurological reports found a strong encephalopathy signal, a median onset of two days and ...
A FAERS analysis of 786 ifosfamide-related neurological reports found a strong encephalopathy signal, a median onset of two days and ...
A dual-database pharmacovigilance analysis identified recurring renal and metabolic reporting signals for finerenone and flagged dizziness, abnormal liver-function results, increased ...
A new cross-platform review of eighteen FDA-approved RNA therapeutics finds that adverse effects depend more on delivery chemistry and administration ...
A case report shows tocilizumab-induced hypofibrinogenemia recurred in a rheumatoid arthritis patient even after the drug dose was substantially reduced.
A year of pharmacovigilance reports from Ho Chi Minh City shows that of 253 confirmed adverse reactions to anticancer drugs, ...
One of the most widely prescribed HIV treatments in the world is now the subject of a large-scale safety review, ...
When a new medicine reaches the market, the work of protecting patients is only beginning. Before approval, clinical trials demonstrate ...
A comprehensive review argues that drug-induced skin phenotypes can act as early, bedside-visible risk signals of systemic toxicity, identifying specific ...
A new multimodal transformer-CNN model called InfoMedex predicts 168 types of drug-drug interactions from molecular structure and uses atom-level attribution ...
A new editorial in Frontiers in Antibiotics highlights six pharmacoepidemiology studies that expose hidden safety signals in newer antibiotics, track ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine